NCT07501013

Brief Summary

This observational study aims to evaluate the long-term recovery and clinical outcomes of patients undergoing minimally invasive (arthroscopic) surgeries for sports-related shoulder and knee injuries. Sports injuries, such as ligament tears, meniscus damage, and rotator cuff tears, are common and can significantly impact a person's daily life and ability to return to sports. While surgery is an effective treatment, the recovery process and final outcomes can vary greatly from person to person. Researchers will follow patients who are already scheduled for routine shoulder or knee surgery at the study center. By collecting detailed information about the patient's initial injury, the specific surgical techniques used by the doctor, and the patient's recovery progress over two years, the study hopes to identify which factors lead to the best healing and functional outcomes. Participants will be asked to complete standard questionnaires about their joint function and pain levels before their surgery, and again at 6 months, 1 year, and 2 years after surgery. The study is strictly observational; it will not change the standard medical care, surgical plan, or rehabilitation routine the patients receive.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
242mo left

Started Apr 2026

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress1%
Apr 2026Apr 2046

First Submitted

Initial submission to the registry

March 24, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 30, 2026

Completed
8 days until next milestone

Study Start

First participant enrolled

April 7, 2026

Completed
20 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 7, 2046

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 7, 2046

Last Updated

April 13, 2026

Status Verified

March 1, 2026

Enrollment Period

20 years

First QC Date

March 24, 2026

Last Update Submit

April 7, 2026

Conditions

Keywords

ArthroscopySports MedicinePatient Reported Outcome MeasuresProspective CohortClinical Outcomes

Outcome Measures

Primary Outcomes (1)

  • Patient-Reported Outcome Measures (PROMs) for Joint Function

    Validated questionnaires evaluate function, symptoms, and QoL based on the specific cohort. 1. Higher scores indicate better outcomes (better function / less symptoms): Score 0 to 100: IKDC, Pedi-IKDC, KOOS, ACL-RSI, WOMET, Kujala AKPS, BPII 2.0, ASES, Rowe score, and EQ-5D VAS. Score 0 to 48: OSIS (Oxford Shoulder Instability) and OSS (Oxford Shoulder). Score 0 to 10: Tegner Activity Scale (higher = higher activity level). Score 0 to 16: Marx Activity Scale (higher = higher activity level). 2. Lower scores indicate better outcomes (less pain / less disability): Score 0 to 10: VAS and NRS (for pain). Score 0 to 100: Quick-DASH (upper extremity disability).

    Preoperative baseline, 2 weeks, 1 month, 6 months, 1 year, and 2 years postoperatively.

Secondary Outcomes (2)

  • Incidence of Postoperative Complications

    From the date of surgery up to 2 years postoperatively.

  • Pain Intensity Assessed by Visual Analog Scale (VAS)

    Preoperative baseline, 2 weeks, 1 month, 6 months, 1 year, and 2 years postoperatively.

Study Arms (2)

Shoulder Cohort

Patients diagnosed with sports-related shoulder injuries (e.g., rotator cuff tear, shoulder instability) who are scheduled to undergo elective, standard-of-care shoulder arthroscopic surgery.

Procedure: Standard of Care Shoulder Arthroscopy

Knee Cohort

Patients diagnosed with sports-related knee injuries (e.g., ACL rupture, meniscus tear) who are scheduled to undergo elective, standard-of-care knee arthroscopic surgery.

Procedure: Standard of Care Knee Arthroscopy

Interventions

Routine, minimally invasive arthroscopic surgical procedures tailored to the patient's specific shoulder pathology, followed by standard postoperative rehabilitation. This is strictly observational; no experimental procedures are introduced.

Shoulder Cohort

Routine, minimally invasive arthroscopic surgical procedures tailored to the patient's specific knee pathology, followed by standard postoperative rehabilitation. This is strictly observational; no experimental procedures are introduced.

Knee Cohort

Eligibility Criteria

Age8 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study population consists of consecutive real-world patients presenting to the sports medicine clinic or inpatient ward at the study center. These are patients who have been diagnosed with shoulder or knee joint pathologies and are scheduled to receive standard-of-care elective surgical treatments.

You may qualify if:

  • Age \>= 8 years.
  • No gender restrictions.
  • Definitive diagnosis of shoulder or knee sports injuries or related joint conditions.
  • Scheduled to undergo elective, standard-of-care surgery at the study center (procedures include but are not limited to: arthroscopic meniscus repair/meniscectomy, cartilage repair, cruciate ligament reconstruction, high tibial osteotomy \[HTO\], unicompartmental knee arthroplasty \[UKA\], arthroscopic rotator cuff repair, shoulder stabilization, and shoulder arthroplasty).
  • Clear consciousness, with the ability to read, understand, and communicate.
  • Willing and able to comply with postoperative follow-up requirements.
  • Voluntarily signed the written informed consent form.

You may not qualify if:

  • Patients requiring emergency surgery due to acute, severe trauma (e.g., open fractures, polytrauma).
  • Coexisting severe neurological or psychiatric diseases, or cognitive impairment that prevents understanding of the informed consent or cooperation with follow-up.
  • Patients in an involuntary state (e.g., under coercion).
  • Refusal to sign the informed consent form or refusal to participate in the study.
  • Currently participating in other interventional clinical trials that may confound or affect the clinical outcomes of this study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Second Affiliated Hospital of Zhejiang University School of Medicine

Hangzhou, Zhejiang, China

RECRUITING

Biospecimen

Retention: SAMPLES WITHOUT DNA

Discarded intraoperative tissues (e.g., synovial fluid, synovial tissue, degenerative meniscus or tendon fragments) and residual routine perioperative blood samples (serum/plasma). These specimens will be retained strictly for histological evaluation, biochemical analysis, and protein/biomarker profiling (e.g., inflammatory cytokines). No DNA extraction or genetic testing will be performed.

MeSH Terms

Conditions

Athletic InjuriesRotator Cuff InjuriesTibial Meniscus InjuriesShoulder DislocationJoint DislocationsAnterior Cruciate Ligament Injuries

Condition Hierarchy (Ancestors)

Wounds and InjuriesRuptureShoulder InjuriesTendon InjuriesLeg InjuriesJoint DiseasesMusculoskeletal DiseasesKnee Injuries

Study Officials

  • Yan Xiong, Doctor

    Department of Orthopedic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

    STUDY CHAIR
  • Weijun Li, Master

    Department of Orthopedic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Yan Xiong, Doctor

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
2 Years
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 24, 2026

First Posted

March 30, 2026

Study Start

April 7, 2026

Primary Completion (Estimated)

April 7, 2046

Study Completion (Estimated)

April 7, 2046

Last Updated

April 13, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be shared publicly in order to strictly protect patient privacy and confidentiality. This decision is in accordance with the regulations of our hospital's Institutional Review Board (IRB) and local data security laws. Only highly aggregated, de-identified statistical data will be presented and published in peer-reviewed academic journals.

Locations